KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 11,620
+520 (4.68%)
At close: Apr 1, 2026
KOREA PHARMA Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2,640 | 3,792 | 83.76 | -1,119 | 6,368 |
Depreciation & Amortization | 3,167 | 2,797 | 2,813 | 2,380 | 2,377 |
Loss (Gain) From Sale of Assets | -1.22 | -1.14 | -0.32 | -81.9 | -5.29 |
Asset Writedown & Restructuring Costs | 222.4 | 279.24 | 606.42 | - | - |
Loss (Gain) From Sale of Investments | -748.22 | -364.1 | -1,910 | 42.2 | -1.93 |
Loss (Gain) on Equity Investments | 278.05 | -1,644 | 1,724 | - | - |
Provision & Write-off of Bad Debts | -33.47 | -187.6 | 214.09 | 103.16 | -157.11 |
Other Operating Activities | 4,855 | 7,797 | 4,856 | 8,436 | 1,440 |
Change in Accounts Receivable | 1,153 | -701.76 | 1,111 | 1,322 | -1,140 |
Change in Inventory | -5,111 | -1,436 | -1,254 | -381.27 | 2,613 |
Change in Accounts Payable | -690.77 | 99.42 | 189.93 | 376.94 | -1,969 |
Change in Other Net Operating Assets | 2,236 | -2,383 | -3,613 | -2,798 | -2,333 |
Operating Cash Flow | 2,687 | 8,046 | 4,819 | 8,279 | 7,192 |
Operating Cash Flow Growth | -66.61% | 66.95% | -41.79% | 15.11% | - |
Capital Expenditures | -19,644 | -3,249 | -1,531 | -2,465 | -2,552 |
Sale of Property, Plant & Equipment | 27.27 | 1.07 | - | 215.41 | 5.3 |
Sale (Purchase) of Intangibles | -81.2 | -552.2 | -1,146 | -287.14 | -897.72 |
Investment in Securities | 11,918 | -8,535 | 47,476 | -49,239 | -8,464 |
Other Investing Activities | 0 | 0 | -0 | - | - |
Investing Cash Flow | -7,779 | -12,335 | 44,899 | -51,875 | -12,908 |
Short-Term Debt Issued | - | - | 4,000 | - | - |
Long-Term Debt Issued | 16,000 | 4,000 | 23,000 | - | 49,997 |
Total Debt Issued | 16,000 | 4,000 | 27,000 | - | 49,997 |
Short-Term Debt Repaid | - | - | -4,000 | -3,000 | -3,000 |
Long-Term Debt Repaid | -4,723 | -18,751 | -39,112 | -1,018 | -1,089 |
Total Debt Repaid | -4,723 | -18,751 | -43,112 | -4,018 | -4,089 |
Net Debt Issued (Repaid) | 11,277 | -14,751 | -16,112 | -4,018 | 45,908 |
Dividends Paid | -545.34 | -545.34 | -545.34 | -545.34 | -545.34 |
Other Financing Activities | -0 | - | -3.43 | - | - |
Financing Cash Flow | 10,732 | -15,296 | -16,661 | -4,563 | 45,363 |
Foreign Exchange Rate Adjustments | -17.87 | 69.72 | -23.44 | 9.36 | 28.69 |
Net Cash Flow | 5,621 | -19,516 | 33,034 | -48,150 | 39,675 |
Free Cash Flow | -16,957 | 4,797 | 3,288 | 5,815 | 4,640 |
Free Cash Flow Growth | - | 45.87% | -43.45% | 25.31% | - |
Free Cash Flow Margin | -19.36% | 5.90% | 3.95% | 7.18% | 5.83% |
Free Cash Flow Per Share | -1554.15 | 440.24 | 272.12 | 535.19 | 421.87 |
Cash Interest Paid | 504.12 | 268.17 | 312.67 | 219.12 | 159.93 |
Cash Income Tax Paid | 903.71 | 202.81 | 2,297 | 348.39 | -354.44 |
Levered Free Cash Flow | -16,964 | 2,639 | -1,693 | 1,395 | 1,004 |
Unlevered Free Cash Flow | -14,735 | 4,439 | 642.87 | 3,812 | 1,571 |
Change in Working Capital | -2,412 | -4,421 | -3,567 | -1,481 | -2,829 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.